NDC 35561-355 – Carbamazepine Er
Carbamazepine 100 mg/1 · Tablet, Extended Release · Oral
Product NDC35561-355
Product details
- Brand name
- Carbamazepine Er
- Generic name
- Carbamazepine
- Labeler
- Bostal LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA215591
- Marketed since
- March 31, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Mood Stabilizer
Active ingredients
- Carbamazepine 100 mg/1
Uses, dosage, side effects and warnings for Carbamazepine Er →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 35561-355-12 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-355-12) | Mar 31, 2022 |
| 35561-355-13 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (35561-355-13) | Apr 9, 2025 |
| 35561-355-99 | 125729 TABLET, EXTENDED RELEASE in 1 DRUM (35561-355-99) | Apr 27, 2025 |
Other Carbamazepine Er products
- 35561-356 Carbamazepine 200 mg/1 · Tablet, Extended Release · Bostal LLC
- 35561-357 Carbamazepine 400 mg/1 · Tablet, Extended Release · Bostal LLC
- 62135-927 Carbamazepine 100 mg/1 · Tablet, Extended Release · Chartwell RX, LLC
- 62135-928 Carbamazepine 200 mg/1 · Tablet, Extended Release · Chartwell RX, LLC
- 62135-930 Carbamazepine 400 mg/1 · Tablet, Extended Release · Chartwell RX, LLC